Hematology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bone Marrow
Researchers from University of Pittsburgh, Department of Surgery discuss findings in bone marrow
April 16th, 2007
New research, "Allopeptide-pulsed dendritic cells and composite tissue allograft survival," is the subject of a report. "Composite tissue allografts (CTAs) contain their own reservoir of vascularized bone marrow, offering novel aspects for the induction of donor-specific tolerance. Additionally, the manipulation of recipient dendritic cells, pulsed with donor allopeptide, has been shown to engender solid organ allograft survival," scientists writing in the journal Microsurgery report. "To exploit these modalities, we have developed a protocol utilizing injection of recipient bone marrow-derived dendritic cells (BMDCs) pulsed with a donor-derived peptide for use...
Source: Hematology Week (2007-04-16)
|
